#None #Drug Development #Xtalks #Genomic Data

How Genomic Data is Transforming Drug Development

In an upcoming free webinar hosted by Xtalks, industry experts will delve into the transformative impact of genomic data on drug development, clinical trials, and health economics outcomes research (HEOR). On June 4, 2026, attendees will gather virtually to gain critical insights into the integration of real-world genomic data and its role in facilitating drug discovery processes while also accelerating clinical research timelines.

Genomic data represents a significant shift in how biopharmaceutical companies are approaching the complexities of drug development. By leveraging clinically validated genomic information along with longitudinal real-world data, stakeholders can improve patient identification, understand disease burden more comprehensively, and enhance overall decision-making. As pharmaceutical teams navigate the challenges of identifying targeted patient populations, they stand to gain remarkably from the specificity that genomic insights provide.

The featured speakers for this session will elaborate on the advantages of utilizing clinical-grade genomic data versus traditional claims data, which often falls short in providing the necessary precision when dealing with genetically-driven diseases. For instance, advancements in data integration allow for a holistic view that connects molecular diagnoses to real-world outcomes, which was often elusive in past methodologies. This detailed framework enables better alignment of therapeutic strategies with patient needs.

One of the key highlights of the webinar will be the introduction of GeneDx Infinity™. This is recognized as one of the largest clinically-derived genomic datasets globally, encompassing over 2.5 million genetic tests alongside 1 million exomes and genomes, paired with 8 million phenotypic datapoints. Inclusion of claims data within this vast dataset aims to empower biopharma teams toward making informed, actionable insights that drive the development process forward. Moreover, the use of multimodal AI within this dataset is revolutionizing biomarker discovery, genetic target validation, and natural history modeling, rendering drug development efforts more efficient.

During the session, participants will also investigate how various aspects such as payer mix and healthcare utilization trends influence the overall landscape of drug development. This entails a spectrum of important discussions surrounding patient demographics, access to care, and the financial burdens posed by rare and genetic diseases. The insights gained could very well redefine the approach toward addressing such conditions, demonstrating the significant economic impact endemic to genomic medicine.

By attending, participants can also explore how genomic data facilitates the generation of robust evidence that underscores development decisions, thereby potentially leading to higher success rates and lower costs in drug discovery and clinical trials. The experts will discuss methods for better evaluating healthcare resource utilization, including hospital visits and overall patient care costs related to genetic diseases.

Event Details:

• - Webinar Title: How Genomic Data Improves Drug Development Timelines and Success
• - Date: Thursday, June 4, 2026
• - Time: 1:00 PM EDT (10:00 AM PDT)
• - Registration Link: Register Here

This webinar aligns with Xtalks' ongoing mission to empower professionals in pharma, biotech, and healthcare to make informed decisions amid an evolving scientific landscape. As the life science community continues to expand, the insights provided during this event will be crucial in supporting future innovations in drug development and patient care.

For more information about the event or to become a part of the life science community that relies on timely intelligence from Xtalks, please visit their website. Don’t miss out on the opportunity to witness how genomic data can massively improve drug development outcomes and redefine patient care standards.